Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
European Journal of Clinical Pharmacology|September 17, 2010
Are results from pharmaceutical-company-sponsored studies available to the public?Rafael Dal-Ré, Alejandro Pedromingo, Manuel García-Losa, et al.Basic & Clinical Pharmacology & Toxicology|December 20, 2024
What participants are told about receiving trial results when they consent to participate in a trialRafael Dal-Ré, Arthur L Caplan, Søren Holm, et al.Medicina Clinica|October 21, 2003
[A validation study of the Spanish versions of the Clinical Anxiety Scale and the Physician Questionnaire for the assessment of anxiety disorders]Antonio Bulbena, Julio Bobes, Antonio Luque, et al.Medicina Clinica|April 27, 2002
[Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales]Antonio Lobo, Lorenzo Chamorro, Antonio Luque, et al.Clinical Trials (London, England)|March 29, 2024
Challenges in conducting efficacy trials for new COVID-19 vaccines in developed countriesRafael Dal-Ré, Emmanuel Bottieau, Odile Launay, et al.Medicina Clinica|June 5, 2003
[A comparative psychometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale]Julio Bobes, Antonio Bulbena, Antonio Luque, et al.Journal of Clinical Psychopharmacology|May 1, 2004
Lack of pharmacologic interaction between paroxetine and alprazolam at steady state in healthy volunteersGonzalo Calvo, Consuelo García-Gea, Antonio Luque, et al.Plos Medicine|January 5, 2012
Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparencyRafael Dal-Ré, David Moher, Christian Gluud, et al.BMC Medicine|July 15, 2026
Inconsistent ethics reporting in individual participant data meta-analyses: a call for updating PRISMA and PRISMA-IPDRafael Dal-Ré, Florence T Bourgeois, Lars G Hemkens, et al.Pageof 9